Literature DB >> 8274847

Tru-cut needle biopsy of subcutaneous fat in the diagnosis of secondary amyloidosis in rheumatoid arthritis.

L Barile1, R Ariza, H Muci, S Pizarro, A Fraga, C Lavalle, R García, D Lescano, R Barrios, A Frati.   

Abstract

In order to investigate the presence of secondary amyloidosis in patients with rheumatoid arthritis (RA), we performed an abdominal subcutaneous fat biopsy with a tru-cut needle in 50 patients. The tissue was stained with Congo red and was observed with polarized light microscopy. We found amyloid deposits in 78% of our patients. We randomly selected ten patients with a positive biopsy and a second procedure was performed. Tissues were studied with electron microscopy. We found unbranched fibrils characteristic of amyloid in all of them. We found a direct correlation with rheumatoid factor titers: the more intense the amyloid deposit, the higher the rheumatoid factor titers (p < 0.001). We did not find any correlation between amyloid deposits and clinical manifestations of disease. Amyloid deposits in RA are more frequent than previously thought, and their clinical importance remains to be determined.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8274847

Source DB:  PubMed          Journal:  Arch Med Res        ISSN: 0188-4409            Impact factor:   2.235


  4 in total

1.  The prevalence of subclinical amyloidosis in Polish patients with rheumatoid arthritis.

Authors:  Piotr Wiland; Renata Wojtala; John Goodacre; Jacek Szechinski
Journal:  Clin Rheumatol       Date:  2004-02-26       Impact factor: 2.980

2.  Amyloid precursor protein and proinflammatory changes are regulated in brain and adipose tissue in a murine model of high fat diet-induced obesity.

Authors:  Kendra L Puig; Angela M Floden; Ramchandra Adhikari; Mikhail Y Golovko; Colin K Combs
Journal:  PLoS One       Date:  2012-01-19       Impact factor: 3.240

3.  Prevalence of amyloid deposition in long standing rheumatoid arthritis in Iranian patients by abdominal subcutaneous fat biopsy and assessment of clinical and laboratory characteristics.

Authors:  G Hussein Alishiri; Ahmad Salimzadeh; Mohammad Bagher Owlia; Jafar Forghanizadeh; Roya Setarehshenas; Nasrin Shayanfar
Journal:  BMC Musculoskelet Disord       Date:  2006-05-15       Impact factor: 2.362

Review 4.  Systemic AA amyloidosis: epidemiology, diagnosis, and management.

Authors:  Diego Real de Asúa; Ramón Costa; Jose María Galván; María Teresa Filigheddu; Davinia Trujillo; Julen Cadiñanos
Journal:  Clin Epidemiol       Date:  2014-10-29       Impact factor: 4.790

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.